(Stroke. 1997;28:1530-1540.)
© 1997 American Heart Association, Inc.
Articles |
A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke
Experience at Eight Centers and Implications for Community Practice and Patient Care
Correspondence to Steven R. Levine, MD, Center for Stroke Research, Department of Neurology (K-11), Henry Ford Hospital and Health Science Center, 2799 W Grand Blvd, Detroit, MI 48202-2689. E-mail stevel{at}neuro.hfh.edu
Background and Purpose With the approval by the Food and Drug Administration of recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke within 180 minutes of symptom onset, patients and prehospital and hospital systems will now have to treat stroke as a medical emergency. It is thus critical to develop efficient hospital-based methods for hyperacute stroke patient evaluation and intervention at both community-based and tertiary care academic centers.
Methods We describe how the eight centers in the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial developed systems for enrolling patients within 3 hours of symptom onset. The actual methodology and practical sequence of events are detailed. Deming principles of system organization were applied, and each center developed a flowchart of acute stroke patient screening, assessment, and treatment. We divided the process into the following: clinical center background and preparation, screening, stroke team response, data needed before treatment, CT of the head, pharmacy, patient treatment, and monitored care. Critical features, both unique to a given center and shared by several centers (common at four or more centers), were summarized.
Results Phase I of the trial included several months of preparation with review of every detail involved in the process of acute stroke care at each site. All centers worked closely with emergency medical services. Community stroke awareness and education programs were developed. A stroke team was initiated and worked closely with the emergency department physicians and nurses. Rapid and efficient communication systems and protocols were established to reduce time to complete each task. Standardized stroke examinations and protocols for blood pressure management and intracranial hemorrhage detection as well as nursing flowcharts were used.
Conclusions Hyperacute stroke treatment can be initiated, often within 55 minutes of patient arrival at the hospital, in both community and academic settings when all aspects of stroke care processes are identified, streamlined, and built into the day-to-day operations of the prehospital and hospital healthcare delivery system.
Key Words: cerebrovascular disorders • emergency medical services • stroke, acute • plasminogen activator, tissue-type • thrombolytic therapy
This article has been cited by other articles:
 |
|
 |
|
  D. Kleindorfer, C. J. Lindsell, L. Brass, W. Koroshetz, and J. P. Broderick National US Estimates of Recombinant Tissue Plasminogen Activator Use: ICD-9 Codes Substantially Underestimate Stroke, March 1, 2008; 39(3): 924 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mosley, M. Nicol, G. Donnan, I. Patrick, F. Kerr, and H. Dewey The Impact of Ambulance Practice on Acute Stroke Care Stroke, October 1, 2007; 38(10): 2765 - 2770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Alexandrov Solving the Issue of Patient Arrival Time: A Call for Vigilant Action Stroke, August 1, 2007; 38(8): 2219 - 2220. [Full Text] [PDF]
|
|
|
|
|
|
S. Roebers, M. Wagner, M. A. Ritter, F. Dornbach, K. Wahle, and P. U. Heuschmann Attitudes and Current Practice of Primary Care Physicians in Acute Stroke Management Stroke, April 1, 2007; 38(4): 1298 - 1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mosley, M. Nicol, G. Donnan, I. Patrick, and H. Dewey Stroke Symptoms and the Decision to Call for an Ambulance Stroke, February 1, 2007; 38(2): 361 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Z. Bambauer, S. C. Johnston, D. E. Bambauer, and J. A. Zivin Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol, May 1, 2006; 63(5): 661 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.N. Sylaja, I. Dzialowski, A. Krol, J. Roy, P. Federico, A. M. Demchuk, and Calgary Stroke Program Role of CT Angiography in Thrombolysis Decision-Making for Patients With Presumed Seizure at Stroke Onset Stroke, March 1, 2006; 37(3): 915 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Part 4: Adult Basic Life Support Circulation, December 13, 2005; 112(24_suppl): IV-19 - IV-34. [Full Text] [PDF]
|
|
|
|
|
|
Part 9: Adult Stroke Circulation, December 13, 2005; 112(24_suppl): IV-111 - IV-120. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Alberts, R. E. Latchaw, W. R. Selman, T. Shephard, M. N. Hadley, L. M. Brass, W. Koroshetz, J. R. Marler, J. Booss, R. D. Zorowitz, et al. Recommendations for Comprehensive Stroke Centers: A Consensus Statement From the Brain Attack Coalition Stroke, July 1, 2005; 36(7): 1597 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Wojner-Alexandrov, A. V. Alexandrov, D. Rodriguez, D. Persse, and J. C. Grotta Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO) Stroke, July 1, 2005; 36(7): 1512 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Jacobs, P. L. Baker, C. Roychoudhury, R. H. Mehta, and S. R. Levine Improved Quality of Stroke Care for Hospitalized Medicare Beneficiaries in Michigan Stroke, June 1, 2005; 36(6): 1227 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Paul Coverdell Prototype Registries Writing Gr Acute Stroke Care in the US: Results from 4 Pilot Prototypes of the Paul Coverdell National Acute Stroke Registry Stroke, June 1, 2005; 36(6): 1232 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Task Force Members, L. H. Schwamm, A. Pancioli, J. E. Acker III, L. B. Goldstein, R. D. Zorowitz, T. J. Shephard, P. Moyer, M. Gorman, S. C. Johnston, et al. Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems Stroke, March 1, 2005; 36(3): 690 - 703. [Full Text] [PDF]
|
|
|
|
|
|
E. C. Haley Jr, P. D. Lyden, K. C. Johnston, T. M. Hemmen, and the TNK in Stroke Investigators A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke Stroke, March 1, 2005; 36(3): 607 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Schwamm, A. Pancioli, J. E. Acker III, L. B. Goldstein, R. D. Zorowitz, T. J. Shephard, P. Moyer, M. Gorman, S. C. Johnston, P. W. Duncan, et al. Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems Circulation, March 1, 2005; 111(8): 1078 - 1091. [Full Text] [PDF]
|
|
|
|
|
|
O. Camilo and L. B. Goldstein Statewide Assessment of Hospital-Based Stroke Prevention and Treatment Services in North Carolina: Changes Over the Last 5 Years Stroke, December 1, 2003; 34(12): 2945 - 2950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Wojner, L. Morgenstern, A. V. Alexandrov, D. Rodriguez, D. Persse, and J. C. Grotta Paramedic and Emergency Department Care of Stroke: Baseline Data From a Citywide Performance Improvement Study Am. J. Crit. Care., September 1, 2003; 12(5): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fisher Recommendations for Advancing Development of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable 3 Stroke, June 1, 2003; 34(6): 1539 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Freedman, R. C. Becker, J. E. Adams, S. Borzak, R. L. Jesse, L. K. Newby, P. O'Gara, J. C. Pezzullo, R. Kerber, B. Coleman, et al. Medication Errors in Acute Cardiac Care: An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke Circulation, November 12, 2002; 106(20): 2623 - 2629. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Broderick and W. Hacke Treatment of Acute Ischemic Stroke: Part I: Recanalization Strategies Circulation, September 17, 2002; 106(12): 1563 - 1569. [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Meschia, D. A. Miller, and T. G. Brott Thrombolytic Treatment of Acute Ischemic Stroke Mayo Clin. Proc., June 1, 2002; 77(6): 542 - 551. [Abstract] [PDF]
|
|
|
|
|
|
C. Ayala, J. B. Croft, K. J. Greenlund, N. L. Keenan, R. S. Donehoo, A. M. Malarcher, and G. A. Mensah Sex Differences in US Mortality Rates for Stroke and Stroke Subtypes by Race/Ethnicity and Age, 1995-1998 Stroke, May 1, 2002; 33(5): 1197 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Merino, B. Silver, E. Wong, B. Foell, B. Demaerschalk, A. Tamayo, F. Poncha, and V. Hachinski Extending Tissue Plasminogen Activator Use to Community and Rural Stroke Patients Stroke, January 1, 2002; 33(1): 141 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Grotta, W. S. Burgin, A. El-Mitwalli, M. Long, M. Campbell, L. B. Morgenstern, M. Malkoff, and A. V. Alexandrov Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke: Houston Experience 1996 to 2000 Arch Neurol, December 1, 2001; 58(12): 2009 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Marler, B. C. Tilley, M. Lu, T. G. Brott, P. C. Lyden, J. C. Grotta, J. P. Broderick, S. R. Levine, M. P. Frankel, S. H. Horowitz, et al. Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study Neurology, December 12, 2000; 55(11): 1649 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Chapman, A. R. Woolfenden, D. Graeb, D. C. C. Johnston, J. Beckman, M. Schulzer, and P. A. Teal Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke : A Canadian Hospital's Experience Stroke, December 1, 2000; 31(12): 2920 - 2924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Brott and J. Bogousslavsky Treatment of Acute Ischemic Stroke N. Engl. J. Med., September 7, 2000; 343(10): 710 - 722. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Alberts, G. Hademenos, R. E. Latchaw, A. Jagoda, J. R. Marler, M. R. Mayberg, R. D. Starke, H. W. Todd, K. M. Viste, M. Girgus, et al. Recommendations for the Establishment of Primary Stroke Centers JAMA, June 21, 2000; 283(23): 3102 - 3109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tanne, M. J. Gorman, V. E. Bates, S. E. Kasner, P. Scott, P. Verro, J. R. Binder, J. M. Dayno, L. R. Schultz, and S. R. Levine Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older : The tPA Stroke Survey Experience Stroke, February 1, 2000; 31(2): 370 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Z. Wang, J. A. Rose, D. S. Honings, D. J. Garwacki, and J. C. Milbrandt Treating Acute Stroke Patients With Intravenous tPA : The OSF Stroke Network Experience Stroke, January 1, 2000; 31(1): 77 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G DEVUYST and J BOGOUSSLAVSKY Recent progress in drug treatment for acute stroke J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 420 - 425. [Full Text] [PDF]
|
|
|
|
|
|
T. G. Kwiatkowski, R. B. Libman, M. Frankel, B. C. Tilley, L. B. Morgenstern, M. Lu, J. P. Broderick, C. A. Lewandowski, J. R. Marler, S. R. Levine, et al. Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year N. Engl. J. Med., June 10, 1999; 340(23): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Levine and M. Gorman "Telestroke" : The Application of Telemedicine for Stroke Stroke, February 1, 1999; 30(2): 464 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Wester, J. Radberg, B. Lundgren, and M. Peltonen Factors Associated With Delayed Admission to Hospital and In-Hospital Delays> in Acute Stroke and TIA : A Prospective, Multicenter Study Stroke, January 1, 1999; 30(1): 40 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Pittman and S. H. Horowitz Tissue-Type Plasminogen Activator Arch Neurol, October 1, 1998; 55(10): 1377 - 1378. [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein, L. A. Hey, and R. Laney North Carolina Stroke Prevention and Treatment Facilities Survey : rtPA Therapy for Acute Stroke Stroke, October 1, 1998; 29(10): 2069 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Slyter Ethical Challenges in Stroke Research Stroke, August 1, 1998; 29(8): 1725 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Fontanarosa and M. A. Winker Timely and Appropriate Treatment of Acute Stroke: What's Missing From This Picture? JAMA, April 22, 1998; 279(16): 1307 - 1309. [Full Text] [PDF]
|
|
|
|
|
|
M. D. Ginsberg and R. Busto Combating Hyperthermia in Acute Stroke : A Significant Clinical Concern Stroke, February 1, 1998; 29(2): 529 - 534. [Abstract] [Full Text] [PDF]
|
|